Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1987 2
1988 3
1989 1
1990 2
1991 3
1992 1
1993 2
1994 6
1995 2
1996 3
1997 1
1998 2
1999 1
2000 1
2001 1
2003 3
2005 1
2006 1
2008 7
2009 8
2010 3
2011 6
2012 6
2013 1
2015 1
2017 1
2018 3
2019 1
2021 2
2022 3
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.
Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, Bushnell MC, Farrar JT, Galer BS, Haythornthwaite JA, Hewitt DJ, Loeser JD, Max MB, Saltarelli M, Schmader KE, Stein C, Thompson D, Turk DC, Wallace MS, Watkins LR, Weinstein SM. Dworkin RH, et al. Among authors: saltarelli m. Arch Neurol. 2003 Nov;60(11):1524-34. doi: 10.1001/archneur.60.11.1524. Arch Neurol. 2003. PMID: 14623723 Review.
Bioanalytical method validation for macromolecules in support of pharmacokinetic studies.
Smolec J, DeSilva B, Smith W, Weiner R, Kelly M, Lee B, Khan M, Tacey R, Hill H, Celniker A, Shah V, Bowsher R, Mire-Sluis A, Findlay JW, Saltarelli M, Quarmby V, Lansky D, Dillard R, Ullmann M, Keller S, Karnes HT. Smolec J, et al. Among authors: saltarelli m. Pharm Res. 2005 Sep;22(9):1425-31. doi: 10.1007/s11095-005-5917-9. Epub 2005 Aug 24. Pharm Res. 2005. PMID: 16132353 Review.
Renal involvement in sarcoidosis: histological patterns and prognosis, an Italian survey.
Rastelli F, Baragetti I, Buzzi L, Ferrario F, Benozzi L, Di Nardo F, Devoti E, Cancarini G, Mezzina N, Napodano P, Gallieni M, Santoro D, Buemi M, Pecchini P, Malberti F, Colombo V, Colussi G, Sabadini E, Remuzzi G, Argentiero L, Gesualdo L, Gatti G, Trevisani F, Slaviero G, Spotti D, Baraldi O, La Manna G, Pignone E, Saltarelli M, Heidempergher M, Tedesco M, Genderini A, Ferro M, Rollino C, Roccatello D, Guzzo G, Clari R, Barbara Piccoli G, Comotti C, Brunori G, Cameli P, Bargagli E, Rottoli P, Dugo M, Cristina Maresca M, Bertoli M, Giozzet M, Brugnano R, Giovanni Nunzi E, D'Amico M, Minoretti C, Acquistapace I, Colturi C, Minola E, Camozzi M, Tosoni A, Nebuloni M, Ferrario F, Dell'Antonio G, Cusinato S, Feriozzi S, Pozzi C. Rastelli F, et al. Among authors: saltarelli m. Sarcoidosis Vasc Diffuse Lung Dis. 2021;38(3):e2021017. doi: 10.36141/svdld.v38i3.11488. Epub 2021 Sep 30. Sarcoidosis Vasc Diffuse Lung Dis. 2021. PMID: 34744417 Free PMC article.
Rare pulmonary manifestation of Ehlers-Danlos syndrome.
Murray RA, Poulton TB, Saltarelli MG, Dweik RA, Litwin DK, Kirby TJ, Meziane MA, O'Donovan PB. Murray RA, et al. Among authors: saltarelli mg. J Thorac Imaging. 1995 Spring;10(2):138-41. doi: 10.1097/00005382-199521000-00012. J Thorac Imaging. 1995. PMID: 7769630
D3 receptor target engagement in humans with ABT-925 using [11C](+)-PHNO PET.
Day M, Bain E, Marek G, Saltarelli M, Fox GB. Day M, et al. Among authors: saltarelli m. Int J Neuropsychopharmacol. 2010 Apr;13(3):291-2. doi: 10.1017/S1461145710000180. Epub 2010 Mar 3. Int J Neuropsychopharmacol. 2010. PMID: 20196920 Free article. No abstract available.
The scopolamine model as a pharmacodynamic marker in early drug development.
Lenz RA, Baker JD, Locke C, Rueter LE, Mohler EG, Wesnes K, Abi-Saab W, Saltarelli MD. Lenz RA, et al. Among authors: saltarelli md. Psychopharmacology (Berl). 2012 Mar;220(1):97-107. doi: 10.1007/s00213-011-2456-4. Epub 2011 Sep 8. Psychopharmacology (Berl). 2012. PMID: 21901320 Clinical Trial.
Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis.
Kloppenburg M, Peterfy C, Haugen IK, Kroon F, Chen S, Wang L, Liu W, Levy G, Fleischmann RM, Berenbaum F, van der Heijde D, Bansal P, Wittoek R, Feng S, Fang Y, Saltarelli M, Medema JK, Levesque MC. Kloppenburg M, et al. Among authors: saltarelli m. Ann Rheum Dis. 2019 Mar;78(3):413-420. doi: 10.1136/annrheumdis-2018-213336. Epub 2018 Dec 14. Ann Rheum Dis. 2019. PMID: 30552176 Free PMC article. Clinical Trial.
68 results